A 14-year-old male presented in 1991 with aplastic anemia associated with paroxysmal nocturnal hemoglobinuria. The patient was maintained on transfusion support until July 1998, when he received an ...
MILFORD, Mass., May 28, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the launch of the BioResolve™ Protein A Affinity Columns with MaxPeak™ Premier Technology, providing precise ...
MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (WAT:NYSE) today introduced new size exclusion chromatography (SEC) columns for the characterization of proteins. For use with Waters ® Alliance ® ...
In recent years, monoclonal antibodies (mAbs) have become one of the major biopharma products in response to the need to treat various diseases. These antibodies have been engineered with a specific ...
Downstream bioprocessing steps have long been a challenge to drug manufacturers, particularly the chromatography step for purification of monoclonal antibodies (mAbs). The complexity of traditional ...
Biomanufacturers face the ongoing challenge of balancing costs and production timelines, with product quality and purity. Join us for this insightful webinar to explore the latest innovations for ...
The consequence of low blood protein depends on how low the protein becomes, which protein is low, and the cause of the low protein. Having a correct level of protein in the blood is essential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback